2026-08-13 – Press Releases – www.prnewswire.com
Following REJURAN®’s TGA approval in 2023, the company hosted scientific sessions and a clinical masterclass for Australian healthcare professionals. GANGNEUNG, South Korea, Aug. 13, 2026 /PRNewswire/ — PharmaResearch, the biopharmaceutical company behind REJURAN®, recently participated…
